Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03732495
Title Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (LENVOS)
Acronym LENVOS
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Angers RECRUITING Angers 49933 France Details
CHRU Besançon RECRUITING Besançon France Details
CHU Bordeaux - Hôpital Saint-André RECRUITING Bordeaux 33075 France Details
Institut Bergonie RECRUITING Bordeaux France Details
Hospices Civils de Lyon - Groupement Hospitalier Est RECRUITING Bron France Details
Centre Geogres François Leclerc RECRUITING Dijon 21079 France Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Centre Antoine Lacassagne RECRUITING Nice France Details
APHP Saint Louis RECRUITING Paris 75010 France Details
APHP La Pitié Salpétrière RECRUITING Paris 75651 France Details
Institut Jean Godinot RECRUITING Reims France Details
Institut du Cancer Strasbourg (ICANS) RECRUITING Strasbourg France Details
Institut Universitaire du Cancer de Toulouse - Oncopole RECRUITING Toulouse France Details
Institut Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field